TET2 and early-onset autosomal dominant Alzheimer disease: Consistently, a published abstract by Wathan et al. reported that bone marrow mutations in Tet2 improved cognitive function and reduced plaque burden in a mouse model of Alzheimer’s disease (Wathan et al., 2022).